EXTENDED THERAPY WITH OZANIMOD FOR DELAYED RESPONDERS TO OZANIMOD IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: DATA FROM THE TRUE NORTH OPEN-LABEL EXTENSION STUDY-MedSci.cn

EXTENDED THERAPY WITH OZANIMOD FOR DELAYED RESPONDERS TO OZANIMOD IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: DATA FROM THE TRUE NORTH OPEN-LABEL EXTENSION STUDY

Panaccione, R; Afzali, A; Hudesman, D; Lawlor, G; Osterman, MT; Eren, D; Memaj, A; Regueiro, MD; Ghosh, S

GASTROENTEROLOGY, 2022; 162 (7): S965

科室
- - 订阅+
  - 更多科室
工具
服务